cancer drug development

Freiburg, Germany, August 31, 2026 Kazia Therapeutics has announced plans to expand its ongoing paxalisib clinical trial into hormone...

Sydney, Australia, September 1, 2026 Kazia Therapeutics has announced plans to expand its ongoing paxalisib clinical trial into hormone...

RAMAT GAN, Israel, September 2, 2026 Can-Fite BioPharma Ltd. reported that blinded overall survival observed across the entire patient...

CHENGDU, China, July 27, 2026 Kelun-Biotech has announced that the Center for Drug Evaluation (CDE) of China’s National Medical...

CAMBRIDGE, UK, July 27, 2026 AstraZeneca has announced positive high-level results from the global Phase III CLARITY-Gastric01 trial, demonstrating...

SHANGHAI, China, June 22, 2026 CureGene Pharmaceutical has announced the successful dosing of the first participant in the U.S....

BOSTON, Singapore and Hong Kong, June 22, 2026 Antengene Corporation Limited has announced a landmark strategic licensing agreement with...

SUZHOU, China, May 29, 2026 Suzhou Ribo Life Science and Ribocure Pharmaceuticals (collectively “Ribo”) have announced the submission of...

SHANGHAI and HONG KONG, China, May 28, 2026 Antengene has announced a major clinical development milestone after receiving endorsement...

NEW YORK, SAN FRANCISCO, and SUZHOU, China, May 28, 2026 Pfizer Inc. and Innovent Biologics have announced a landmark...